Novel insights into amylin aggregation
- PMID: 26019498
- PMCID: PMC4434089
- DOI: 10.1080/13102818.2014.901680
Novel insights into amylin aggregation
Abstract
Amylin is a peptide that aggregates into species that are toxic to pancreatic beta cells, leading to type II diabetes. This study has for the first time quantified amylin association and dissociation kinetics (association constant (ka ) = 28.7 ± 5.1 L mol-1 s-1 and dissociation constant (kd ) = 2.8 ± 0.6 ×10-4 s-1) using surface plasmon resonance (SPR). Thus far, techniques used for the sizing of amylin aggregates do not cater for the real-time monitoring of unconstrained amylin in solution. In this regard we evaluated recently innovated nanoparticle tracking analysis (NTA). In addition, both SPR and NTA were used to study the effect of previously synthesized amylin derivatives on amylin aggregation and to evaluate their potential as a cell-free system for screening potential inhibitors of amylin-mediated cytotoxicity. Results obtained from NTA highlighted a predominance of 100-300 nm amylin aggregates and correlation to previously published cytotoxicity results suggests the toxic species of amylin to be 200-300 nm in size. The results seem to indicate that NTA has potential as a new technique to monitor the aggregation potential of amyloid peptides in solution and also to screen potential inhibitors of amylin-mediated cytotoxicity.
Keywords: amylin; nanoparticle tracking analysis; surface plasmon resonance; type II diabetes.
Figures





Similar articles
-
Rapid assessment of human amylin aggregation and its inhibition by copper(II) ions by laser ablation electrospray ionization mass spectrometry with ion mobility separation.Anal Chem. 2015 Oct 6;87(19):9829-9837. doi: 10.1021/acs.analchem.5b02217. Anal Chem. 2015. PMID: 26352401 Free PMC article.
-
Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetes.Interface Focus. 2017 Dec 6;7(6):20160127. doi: 10.1098/rsfs.2016.0127. Epub 2017 Oct 20. Interface Focus. 2017. PMID: 29147551 Free PMC article.
-
Computational and Experimental Approaches to Design Inhibitors of Amylin Aggregation.Curr Drug Targets. 2019;20(16):1680-1694. doi: 10.2174/1389450120666190719164316. Curr Drug Targets. 2019. PMID: 31333136 Review.
-
Nano-scale imaging and dynamics of amylin-membrane interactions and its implication in type II diabetes mellitus.Methods Cell Biol. 2008;90:267-86. doi: 10.1016/S0091-679X(08)00813-3. Methods Cell Biol. 2008. PMID: 19195555
-
Role and Cytotoxicity of Amylin and Protection of Pancreatic Islet β-Cells from Amylin Cytotoxicity.Cells. 2018 Aug 6;7(8):95. doi: 10.3390/cells7080095. Cells. 2018. PMID: 30082607 Free PMC article. Review.
Cited by
-
Protein aggregation and neurodegenerative disease: Structural outlook for the novel therapeutics.Proteins. 2025 Aug;93(8):1314-1329. doi: 10.1002/prot.26561. Epub 2023 Aug 2. Proteins. 2025. PMID: 37530227 Free PMC article. Review.
References
-
- Kruger DF, Gatcomb PM, Owen SK. Diabetes Educator. 1999;25:389–397. http://dx.doi.org/10.1177/014572179902500310 - DOI - PubMed
-
- Martin C. Diabetes Educator. 2006;32:101–104. - PubMed
-
- Badman MK, Shennan KIJ, Jermany JL, Docherty K, Clark A. FEBS Lett. 1996;378:227, 231. - PubMed
-
- Kayed R, Bernhagen J, Greenfield N, Sweimeh K, Brunner H, Voelter W, Kapurniotu A. J Mol Biol. 1999;287:781–796. - PubMed
-
- Kodali R, Wetzel R. Curr Opin Struct Biol. 2007;17:48–57. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources